NASDAQ · Financial Statements

InflaRx N.V. (IFRX) Revenue, Earnings & Financial Statements

$1.15 NASDAQ: IFRX Market Cap $169.47M

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

InflaRx N.V. most recently reported annual revenue of 0, a net loss of 46.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

InflaRx N.V.: net profit was positive in 0 of 10 reported years; operating margin moved from -70685.6% to -164525.5%, a shift of -93839.9 percentage points; the most recent year shows a net loss of 46.0M.

Income Statement — 10 Years (millions, reporting currency)

Metric2016201720182019202020212022202320242025
Revenue0000000000
Operating Expenses7.0M19.0M38.0M57.0M34.0M48.0M32.0M45.0M53.0M48.0M
Operating Profit−7.0M−19.0M−38.0M−57.0M−34.0M−48.0M−32.0M−45.0M−53.0M−48.0M
Operating Margin———————-70685.6%-31911.4%-164525.5%
Other Income−2.0M−5.0M8.0M4.0M02.0M3.0M2.0M7.0M3.0M
Interest2.0M2.0M00000000
Depreciation0001.0M1.0M1.0M1.0M1.0M00
Profit Before Tax−9.0M−24.0M−30.0M−53.0M−34.0M−46.0M−29.0M−43.0M−46.0M−46.0M
Tax rate (%)0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%-0.0%-0.0%
Net Profit−9.0M−24.0M−30.0M−53.0M−34.0M−46.0M−29.0M−43.0M−46.0M−46.0M
EPS−0.38−1.03−1.19−1.91−1.26−1.10−0.61−0.78−0.78−0.66

Quarterly Results — Last 12 Quarters (millions, reporting currency)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue000000000000
Operating Expenses13.0M13.0M15.0M15.0M10.0M13.0M13.0M10.0M13.0M7.0M7.0M6.0M
Operating Profit−13.0M−12.0M−15.0M−15.0M−10.0M−13.0M−13.0M−9.0M−13.0M−7.0M−7.0M−6.0M
Operating Margin-582075.0%-34655.2%-242200.1%-12405.2%2308149.2%—-32524.7%-39769.2%37891.1%———
Interest000000000000
Profit Before Tax−16.0M−10.0M−13.0M−17.0M−5.0M−8.0M−14.0M−12.0M−11.0M−6.0M−11.0M−2.0M
Tax rate (%)0.0%0.0%0.0%-0.0%0.0%0.0%0.0%-0.1%0.0%0.0%0.0%0.0%
Net Profit−16.0M−10.0M−14.0M−17.0M−5.0M−8.0M−14.0M−12.0M−11.0M−6.0M−11.0M−2.0M
EPS−0.26−0.16−0.24−0.30−0.09−0.13−0.21−0.18−0.14−0.08−0.09−0.02

Over the 10 years reported for InflaRx N.V., borrowings decreased from 53.0M in 2016 to 1.0M in 2025, cash stood at 16.0M in the latest year, shareholders' equity was 9.0M, current assets covered current liabilities 4.15 times.

Balance Sheet — 10 Years (millions, reporting currency)

Metric2016201720182019202020212022202320242025
Total Assets30.0M124.0M159.0M122.0M88.0M125.0M102.0M120.0M76.0M55.0M
Current Assets29.0M124.0M158.0M119.0M86.0M96.0M97.0M109.0M72.0M54.0M
Cash29.0M123.0M55.0M33.0M26.0M26.0M16.0M13.0M18.0M16.0M
Inventory01.0M0000011.0M7.0M0
Receivables000001.0M1.0M001.0M
Fixed Assets001.0M1.0M1.0M2.0M2.0M1.0M1.0M1.0M
Capital Work in Progress0000000000
Investments00101.0M83.0M55.0M84.0M68.0M9.0M3.0M31.0M
Other Assets0000000000
Total Liabilities55.0M5.0M8.0M14.0M10.0M20.0M14.0M18.0M15.0M14.0M
Current Liabilities2.0M5.0M8.0M14.0M10.0M19.0M13.0M17.0M14.0M13.0M
Borrowings53.0M001.0M1.0M1.0M1.0M1.0M1.0M1.0M
Other Liabilities2.0M5.0M8.0M14.0M10.0M18.0M13.0M17.0M14.0M13.0M
Equity03.0M3.0M3.0M3.0M5.0M5.0M7.0M7.0M9.0M
Reserves−26.0M119.0M151.0M107.0M78.0M105.0M88.0M103.0M61.0M42.0M

For InflaRx N.V., operating cash flow was positive in 0 of 10 reported years; free cash flow in the latest year was negative at 34.0M; free cash flow was positive in 0 of 10 years.

Cash Flow Statement — 10 Years (millions, reporting currency)

Metric2016201720182019202020212022202320242025
Operating Cash Flow−5.0M−12.0M−24.0M−43.0M−37.0M−40.0M−34.0M−38.0M−49.0M−34.0M
Investing Cash Flow00−100.0M20.0M21.0M−26.0M19.0M−18.0M52.0M3.0M
Financing Cash Flow0−9.0M−3.0M00−3.0M0−3.0M00
Net Cash Flow26.0M94.0M−68.0M−22.0M−7.0M0−10.0M−3.0M6.0M0
Free Cash Flow−5.0M−12.0M−25.0M−44.0M−37.0M−40.0M−34.0M−38.0M−49.0M−34.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.08
EV / EBITDA-4.54
FCF Yield-8.94%
Quick Ratio7.26
Interest Coverage-547.04
Return 1Y-7.87%
Return 3Y-22.00%
Return 5Y-78.85%

InflaRx N.V. (IFRX) financials — frequently asked questions

What is InflaRx N.V.'s annual revenue?

InflaRx N.V. (IFRX) reported annual revenue of 0 in its most recent fiscal year.

What is InflaRx N.V.'s net profit?

InflaRx N.V. (IFRX) reported a net loss of 46.0M in its most recent fiscal year.

What is IFRX EV/EBITDA?

InflaRx N.V.'s enterprise value to EBITDA (EV/EBITDA) ratio is -4.54. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Revenue and earnings of other Biotechnology stocks

VRTX revenue $12.1BREGN revenue $14.3BMRNA revenue $1.9BRVMD financialsROIV revenue $8.0MINSM revenue $606.0MUTHR revenue $3.2BINCY revenue $5.1BALNY revenue $3.7BASND revenue $692.0MAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
IFRX Overview IFRX Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.